Buteyko Method for Asthmatic Children With Mouth Breathing

NCT02724657 | Completed

• 1 other identifier: 1.443.588
• Study Type: interventional
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

To assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of asthmatic children with mouth breathing.

Conditions

Asthma; Mouth Breathing

Keywords

Child; Breathing exercises

Outcome Measures

Primary Outcomes (1)

• Change in Sleep disturbance (questionnaire)

  Sleep disturbance will be assessed by the sleep disturbance scale for children (SDSC).

  Baseline, three weeks later and six months after treatment

Secondary Outcomes (4)

• Change in spirometry (FVC, FEV1, FEV1/FVC, FEF25-75%, PEF)

  Baseline, three weeks later and six months after treatment

• Change in ventilometry (minute volume and vital capacity)

  Baseline, three weeks later and six months after treatment

• Number of hospitalizations

  Through study completion, an average of three weeks and six months after treatment

• Number of days off-school

  During the three weeks of treatment

Study Arms (2)

Buteyko Method

EXPERIMENTAL

Children will perform 6 sessions (twice a week) of treatment with the Buteyko Method.

Other: Buteyko Method

Control

NO INTERVENTION

Asthma education.

Interventions

Buteyko Method OTHER

Intervention will be held twice a week during 3 weeks.

Buteyko Method

Eligibility Criteria

• Age: 7 Years - 12 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Children from 7 up to 12 years old with asthma diagnose
• Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks.
• Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, and tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.

You may not qualify if:

• Children that are not able to perform some of the necessary procedures, give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Sponsors & Collaborators

• Universidade Federal do Rio Grande do Norte: lead

Study Sites (1)

Universidade Federal do Rio Grande do Norte (UFRN)

Natal, Rio Grande do Norte, 59078970, Brazil

Location

MeSH Terms

Conditions

Asthma; Mouth Breathing

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: March 7, 2016
• First Posted: March 31, 2016
• Study Start: March 1, 2016
• Primary Completion: August 1, 2016
• Study Completion: October 1, 2016
• Last Updated: January 24, 2017

Record last verified: 2017-01

Locations

BR (1)